Eprotirome

DRUG2 trials

Sponsors

Karo Bio AB

Conditions

Heterozygous Familial HypercholesterolaemiaPrimary Hypercholesterolemia

Phase 2

Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia

CompletedNCT00776321

Karo Bio ABPrimary Hypercholesterolemia

Start: 2006-09-30End: 2007-10-31Updated: 2008-10-21

Phase 3

Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care

TerminatedNCT01410383

Karo Bio ABHeterozygous Familial Hypercholesterolaemia

Start: 2011-10-31End: 2014-10-31Updated: 2012-09-03

Related Papers

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study.

2014-02-1891 citations